Breaking News Instant updates and real-time market news.

ATH

Athene Holding

$45.69

0.24 (0.53%)

, AVXS

AveXis

$49.08

-0.91 (-1.82%)

08:30
12/22/16
12/22
08:30
12/22/16
08:30

Three new option listings and one option delisting on December 22nd

New option listings for December 22nd include Athene Holding Ltd (Class A Stock) (ATH), AveXis (AVXS), and Profire Energy (PFIE). Option delistings effective December 22nd include Carmike Cinemas (CKEC).

ATH

Athene Holding

$45.69

0.24 (0.53%)

AVXS

AveXis

$49.08

-0.91 (-1.82%)

PFIE

Profire Energy

$1.31

-0.0909 (-6.49%)

CKEC

Acquired by AMC

ATH Athene Holding
$45.69

0.24 (0.53%)

AVXS AveXis
$49.08

-0.91 (-1.82%)

11/02/16
BMOC
11/02/16
NO CHANGE
BMOC
AveXis price target raised to $80 from $52 at BMO Capital
BMO Capital analyst M. Ian Somaiya pulled forward his time frame for FDA approval of AveXis' AVXS-101m drug by 12 months. The analyst now sees a roughly 70% chance of the drug launching by late 2017 to early 2018 if the FDA accepts the company's Phase I filing. The analyst says that the FDa's willingness to accept the company's 20 patient Phase II trial shows the strength of the Phase I data. He keeps an Outperform rating o nthe shares.
11/07/16
PIPR
11/07/16
NO CHANGE
PIPR
Biogen, Ionis get jump start on AveXis, says Piper Jaffray
Piper Jaffray analyst Joshua Schimmer says that following his upgrade this morning, Biogen (BIIB) and its partner Ionis Pharmaceuticals (IONS) announced that a Phase III study of nusinersen met its primary endpoint. The data look "very good," Schimmer tells investors in a research note. This gives Biogen and Ionis a jump start on rival gene therapy player AveXis for the Type II/III setting, Schimmer tells investors in a research note. If not for competition from AveXis, nusinersen would become a $5B-plus mega-blockbuster by addressing one of the highest unmet needs in pediatric diseases that exists today, the analyst contends. Schimmer believes, however, that AveXis is moving quickly to compete in the market. The analyst still hopes Biogen "will find a way to partner" with AveXis. He still thinks nusinersen, which is now called SPINRAZA, can achieve $1B-$2B-plus in peak annual revenue. Following this morning's upgrade, Schimmer has an Overweight rating on Biogen with a $335 price target.
11/14/16
STFL
11/14/16
INITIATION
Target $65
STFL
Hold
AveXis initiated with a Hold at Stifel
Stifel analyst Katherine Breedis initiated AveXis with a Hold and a $65 price target.
11/30/16
GSCO
11/30/16
NO CHANGE
Target $91
GSCO
Buy
AveXis price target raised to $91 from $71 at Goldman
Goldman analyst Salveen Richter raised AveXis' price target to $91 from $71 to reflect a shorter time to peak penetration of AVXS-101 to 4 years from 5 years prior. Richter also added Japan and ROW sales to AVXS-101 resulting in peak sales estimate of $925M from $805M in 2026. The analyst maintains a 2020 US launch but awaits visibility on the accelerated approval pathway on the current Phase 1 data expected in 1H 2017 and reiterates his Buy rating on shares.
PFIE Profire Energy
$1.31

-0.0909 (-6.49%)

01/27/16
CHDN
01/27/16
DOWNGRADE
CHDN
Neutral
Profire Energy downgraded to Neutral from Buy at Chardan
12/15/16
CHDN
12/15/16
UPGRADE
CHDN
Buy
Profire Energy upgraded to Buy from Neutral at Chardan
01/27/16
01/27/16
DOWNGRADE

On The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: BG Group (BRGYY) downgraded to Neutral from Outperform at Credit Suisse... Bed Bath & Beyond (BBBY) downgraded to Sell from Neutral at Citi... Bill Barrett (BBG) downgraded to Neutral from Buy at Ladenburg... Brown & Brown (BRO) downgraded to Underweight at Morgan Stanley... Buffalo Wild Wings (BWLD) downgraded to Neutral from Buy at BTIG... Canadian National (CNI) downgraded to Market Perform from Outperform at Raymond James... DreamWorks (DWA) downgraded to Sell from Hold at Topeka... FirstMerit (FMER) downgraded at RBC Capital... Gentex (GNTX) downgraded to Neutral from Outperform at Baird... Haverty Furniture (HVT) downgraded to Sector Weight from Overweight at KeyBanc... Hercules Technology (HTGC) downgraded to Neutral from Buy at Compass Point... Horizon Technology (HRZN) downgraded to Market Perform from Outperform at Raymond James... Installed Building downgraded to Sector Weight from Overweight at KeyBanc... Jarden (JAH) downgraded to Neutral from Buy at Citi... K+S (KPLUF) downgraded to Sell from Hold at Berenberg... La-Z-Boy (LZB) downgraded at BB&T... Legacy Reserves (LGCY) downgraded to Market Perform from Outperform at FBR Capital... Medivation (MDVN) downgraded to Hold from Buy at Canaccord... Merck (MRK) downgraded to Neutral from Buy at BofA/Merrill... Metaldyne Performance (MPG) downgraded to Neutral from Outperform at Baird... Pier 1 Imports (PIR) downgraded to Sector Weight from Overweight at KeyBanc... Priceline (PCLN) downgraded to Neutral from Buy at Goldman... Profire Energy (PFIE) downgraded to Neutral from Buy at Chardan... Regeneron (REGN) downgraded to Hold at Canaccord... Starwood (HOT) downgraded to Underperform from Outperform at CLSA... Swiss Re (SSREY) downgraded to Equal Weight from Overweight at Morgan Stanley... TSYS (TSS) downgraded to Equal-Weight from Overweight at First Analysis... Talmer Bancorp (TLMR) downgraded to Sector Perform from Outperform at RBC Capital... TopBuild (BLD) downgraded to Sector Weight from Overweight at KeyBanc... TripAdvisor (TRIP) downgraded to Sell from Neutral at Goldman... VMware (VMW) downgraded to Hold from Buy at Summit Research... W.R. Grace (GRA) downgraded to Buy from Conviction Buy at Goldman... WEC Energy (WEC) downgraded to Neutral from Conviction Buy at Goldman... Welltower (HCN) downgraded to Underperform from Market Perform at BMO Capital... Yamana Gold (AUY) downgraded to Neutral from Overweight at JPMorgan.
CKEC Acquired by AMC

03/09/16
MACQ
03/09/16
DOWNGRADE
MACQ
Neutral
Carmike Cinemas downgraded to Neutral from Outperform at Macquarie
Carmike Cinemas (CKEC) is being acquired by AMC Entertainment (AMC) for $30 per share in cash.
04/13/16
WEDB
04/13/16
NO CHANGE
WEDB
National CineMedia attractive after recent weakness, says Wedbush
Wedbush believes that National CineMedia's (NCMI) valuation is attractive at current levels, partly due to what it sees as the company's "undemanding Q1 guidance," "confusion" about Carmike's (CKEC) acquisition by AMC (AMC), and the "continuing secular advantages of cinema advertising." The firm thinks that the Carmike deal could benefit National CineMedia over the longer term by enabling it to work with and/or replace Screenvision as Carmike's ad network partner. . Wedbush keeps a $19 price target and Outperform rating on National CineMedia.
06/17/16
PIPR
06/17/16
NO CHANGE
PIPR
AMC could boost Carmike takeover offer by $2-$3.50 per share, says Piper Jaffray
Piper Jaffray analyst Alex Olvera said that after holding a conference call with the largest shareholder of Carmike (CKEC), Driehaus Capital, that he believes Driehaus and another big stakeholder, Mittleman Investment, may vote against the company's merger deal with AMC Entertainment (AMC). He added that he is not sure if these holders would look to perfect appraisal rights, but said that to avoid costs associated with such a scenario that AMC could decide to raise its offer by $2-$3.50 per share for all Carmike shareholders.
07/12/16
PIPR
07/12/16
NO CHANGE
Target $35
PIPR
Overweight
AMC acquisition puts Carmike deal at risk, says Piper Jaffray
Piper Jaffray analyst Stan Meyers believes AMC Entertainment's (AMC) acquisition of Europe's largest theater chain Odeon puts its deal with Carmike Cinemas (CKEC) at risk. The pressure on AMC to complete the Carmike deal in 2016 is "largely off the table, increasing the risk of the deal falling apart by the end of the week," Meyers tells investors in a research note. AMC management seems willing to raise its bid and potentially throw in some equity, though not to the levels expected by the Carmike key stakeholders, the analyst contends. He thinks Odeon should accelerate AMC's EBITDA growth over time. Further, the AMC/Odeon deal should also accelerate IMAX's (IMAX) expansion in Europe, Meyers contends.

TODAY'S FREE FLY STORIES

SIRI

SiriusXM

$5.40

0.02 (0.37%)

12:45
11/17/17
11/17
12:45
11/17/17
12:45
Options
Sirius XM call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:45
11/17/17
11/17
12:45
11/17/17
12:45
General news
Breaking General news story  »

Week of 11/17…

FL

Foot Locker

$39.80

7.95 (24.96%)

12:32
11/17/17
11/17
12:32
11/17/17
12:32
Upgrade
Foot Locker rating change  »

Deutsche sees sustained…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

XRT

S&P Retail Index SPDR

$41.59

0.98 (2.41%)

12:30
11/17/17
11/17
12:30
11/17/17
12:30
Options
Defensive short-term play in SPDR Retail ETF »

Defensive short-term play…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

12:30
11/17/17
11/17
12:30
11/17/17
12:30
General news
Breaking General news story  »

San Francisco Federal…

FTI

TechnipFMC

$26.72

0.175 (0.66%)

12:25
11/17/17
11/17
12:25
11/17/17
12:25
Options
FMC Technologies call volume above normal and directionally bullish »

Bullish option flow…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

$NSD

NASDAQ Market Internals

12:17
11/17/17
11/17
12:17
11/17/17
12:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMD

AMD

$11.25

0.18 (1.63%)

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Options
AMD calls outpace puts 4:1 as shares advance »

AMD calls outpace puts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

TSLA

Tesla

$312.50

1.2 (0.39%)

, AMZN

Amazon.com

$1,137.29

10.6 (0.94%)

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Hot Stocks
Tesla, Amazon look to shake up trucking industry with new vehicle, app »

Shares of third-party…

TSLA

Tesla

$312.50

1.2 (0.39%)

AMZN

Amazon.com

$1,137.29

10.6 (0.94%)

CHRW

C.H. Robinson

$80.40

0.45 (0.56%)

LSTR

Landstar System

$96.80

1.75 (1.84%)

XPO

XPO Logistics

$74.29

0.1035 (0.14%)

JBHT

J.B. Hunt

$102.98

1.44 (1.42%)

WMT

Wal-Mart

$96.94

-2.68 (-2.69%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

  • 20

    Nov

  • 21

    Nov

  • 21

    Nov

  • 28

    Nov

  • 07

    Dec

  • 11

    Dec

  • 09

    Jan

  • 16

    Jan

  • 20

    Feb

  • 18

    Mar

$NYE

NYSE Market Internals

12:16
11/17/17
11/17
12:16
11/17/17
12:16
Technical Analysis
NYSE market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MDXG

MiMedx

$11.36

-0.58 (-4.86%)

12:12
11/17/17
11/17
12:12
11/17/17
12:12
Recommendations
MiMedx analyst commentary  »

MiMedx growth…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    Nov

  • 30

    Nov

  • 01

    Dec

XOP

SPDR Oil Exploration and Production Fund

$34.83

0.525 (1.53%)

12:00
11/17/17
11/17
12:00
11/17/17
12:00
Options
Defensive short-term option play in SPDR Oil Exploration and Production ETF »

Defensive short-term…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

TNK

Teekay Tankers

$1.41

0.01 (0.71%)

11:55
11/17/17
11/17
11:55
11/17/17
11:55
Conference/Events
Teekay Tankers to host special shareholder meeting »

Special shareholder…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

TWX

Time Warner

$88.53

0.52 (0.59%)

, VIA

Viacom

$30.10

-0.65 (-2.11%)

11:50
11/17/17
11/17
11:50
11/17/17
11:50
Hot Stocks
Box Office Battle: 'Justice League' to vanquish 'Thor' in debut »

The major release opening…

TWX

Time Warner

$88.53

0.52 (0.59%)

VIA

Viacom

$30.10

-0.65 (-2.11%)

VIAB

Viacom

$23.69

-0.92 (-3.74%)

LGF.A

Lionsgate

$32.32

1.28 (4.12%)

LGF.B

Lionsgate

$30.70

1.17 (3.96%)

DIS

Disney

$103.61

0.01 (0.01%)

FOX

21st Century Fox

$28.60

0.65 (2.33%)

FOXA

21st Century Fox

$29.32

0.59 (2.05%)

CMCSA

Comcast

$37.07

-0.11 (-0.30%)

CMCSK

Comcast

SNE

Sony

$46.20

0.1 (0.22%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

ANF

Abercrombie & Fitch

$15.49

2.9398 (23.42%)

11:50
11/17/17
11/17
11:50
11/17/17
11:50
Recommendations
Abercrombie & Fitch analyst commentary  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

HFWA

Heritage Financial

$30.60

0.3 (0.99%)

11:48
11/17/17
11/17
11:48
11/17/17
11:48
Hot Stocks
Heritage Financial, Puget Sound Bancorp deal receives regulatory approvals »

Heritage Financial, the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EEM

MSCI Emerging Markets Index

$46.81

0.215 (0.46%)

11:40
11/17/17
11/17
11:40
11/17/17
11:40
Options
108K iShares Emerging Markets Fund Dec 44.5 puts bought for 22c »

108K iShares Emerging…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

11:35
11/17/17
11/17
11:35
11/17/17
11:35
General news
Euro$ interest rate futures recovered from lows »

Euro$ interest rate…

ANF

Abercrombie & Fitch

$16.00

3.45 (27.49%)

11:31
11/17/17
11/17
11:31
11/17/17
11:31
Downgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

M

Macy's

$20.63

0.38 (1.88%)

11:30
11/17/17
11/17
11:30
11/17/17
11:30
Options
Calendar risk reversal in Macys may roll call gains into put protection »

Calendar risk reversal in…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 18

    Mar

ANF

Abercrombie & Fitch

$15.94

3.39 (27.01%)

11:28
11/17/17
11/17
11:28
11/17/17
11:28
Downgrade
Abercrombie & Fitch rating change  »

Abercrombie & Fitch…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 17

    Nov

AAPL

Apple

$171.10

2.02 (1.19%)

11:24
11/17/17
11/17
11:24
11/17/17
11:24
Periodicals
Apple delays release of HomePod to early 2018, TechCrunch reports »

Apple is delaying the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

V

Visa

$110.15

-0.87 (-0.78%)

, MA

MasterCard

$148.53

-1.7995 (-1.20%)

11:23
11/17/17
11/17
11:23
11/17/17
11:23
Recommendations
Visa, MasterCard analyst commentary  »

Visa highlights possible…

V

Visa

$110.15

-0.87 (-0.78%)

MA

MasterCard

$148.53

-1.7995 (-1.20%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Nov

  • 29

    Nov

GLD

SPDR Gold Trust

$122.32

0.92 (0.76%)

11:20
11/17/17
11/17
11:20
11/17/17
11:20
Options
Far downside put buyers in SPDR Gold ETF as the metal trades higher »

Far downside put buyers…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

$NSD

NASDAQ Market Internals

11:17
11/17/17
11/17
11:17
11/17/17
11:17
Technical Analysis
NASDAQ market internals summary »

Volume is average for…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.